Araris Biotech Ag

Araris Biotech Ag company information, Employees & Contact Information

Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.

Company Details

Employees
20
Founded
-
Address
Riedhofstrasse 11, Au,zh 8804,switzerland
Phone
+41 56 310 45 98
Email
in****@****ech.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Au, ZH
Looking for a particular Araris Biotech Ag employee's phone or email?

Araris Biotech Ag Questions

News

Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech - GlobeNewswire

Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech GlobeNewswire

Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQ™ technology - GlobeNewswire

Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQ™ technology GlobeNewswire

Araris Biotech Publishes Foundational Science Behind its Novel Antibody-Drug Conjugate Platform in ChemBioChem - Yahoo Finance

Araris Biotech Publishes Foundational Science Behind its Novel Antibody-Drug Conjugate Platform in ChemBioChem Yahoo Finance

Araris Biotech acquired by Taiho Pharmaceutical to accelerate ADC drug discovery - Venturelab Swiss

Araris Biotech acquired by Taiho Pharmaceutical to accelerate ADC drug discovery Venturelab Swiss

One-Step ADC Linker Approach Bypasses Antibody Engineering - Genetic Engineering and Biotechnology News

One-Step ADC Linker Approach Bypasses Antibody Engineering Genetic Engineering and Biotechnology News

Otsuka's Taiho pays $400M for Swiss partner to 'turbocharge' 3 ADCs to clinic - Fierce Biotech

Otsuka's Taiho pays $400M for Swiss partner to 'turbocharge' 3 ADCs to clinic Fierce Biotech

Araris Biotech achieves unicorn status - Switzerland Global Enterprise

Araris Biotech achieves unicorn status Switzerland Global Enterprise

Schroders Capital Global Innovation’s Araris Biotech sold to Taiho Pharmaceutical - QuotedData

Schroders Capital Global Innovation’s Araris Biotech sold to Taiho Pharmaceutical QuotedData

New ADC Linker Tech Shows Efficacy, Safety Advantages - Bioprocess Online

New ADC Linker Tech Shows Efficacy, Safety Advantages Bioprocess Online

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion - GlobeNewswire

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion GlobeNewswire

Araris Biotech AG Expands its IP Portfolio with the - GlobeNewswire

Araris Biotech AG Expands its IP Portfolio with the GlobeNewswire

Top Araris Biotech Ag Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant